<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72196">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01920542</url>
  </required_header>
  <id_info>
    <org_study_id>GCIRB2013-163</org_study_id>
    <nct_id>NCT01920542</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine on Pediatric Heart Operation</brief_title>
  <official_title>Renal Effects of Dexmedetomidine During Pediatric Cardiac Surgery: a Randomized Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      we hypothized dexmedetomidine could reduce the reduction of renal function after
      cardiopulmonary bypass weaning in pediatric patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      dexmedetomidine, a2-adrenoreceptor agonist has been used for sedation or hemodynamic
      stability for operative procedure. It had been already reported that dexmedetomidine reduce
      the impairment of renal functon after cardiac operation in adult. we hypothized
      dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass
      weaning in pediatric patients
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>renal function</measure>
    <time_frame>from anesthetic induction up to postoperative 2h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>at immediate after anesthetic induction (baseline),  after weaning of cardiopulmonary bypass, 2h after end of operationCPB, sodium and creatinine in the urine and serum, N-acetyl-b-glucosaminidase (NAG)and albumin in only urine could be studied</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Acute Renal Injury</condition>
  <arm_group>
    <arm_group_label>no dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>no administration of dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administration of 0.5ug/kg dexmedetomidine for 10 min and infusion of 0.5ug/kg/h of dexmedetomidine until weaning of cardiopulmonary bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>administration of dexmedetomidine on dexemedetomidine group</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>administration of dexmedetomidine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>no dexmedetomidine</intervention_name>
    <description>no administration of dexmedetomidine on control group</description>
    <arm_group_label>no dexmedetomidine</arm_group_label>
    <other_name>no administration of dexmedetomidine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1-6yr pediatric cardiac patients

        Exclusion Criteria:

          -  previous renal dysfunction
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung Cheon Lee, M.D., Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Gachon University Gil Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyun Jeong Kwak, M.D.,Ph.D</last_name>
    <phone>82-32-460-3400</phone>
    <email>hyun615@gilhospital.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kyung Cheon Lee, M.D.,Ph.D</last_name>
    <phone>82-32-460-3419</phone>
    <email>leekc@gilhospital.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gachon University Gil Medical Cneter</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kyung Cheon Lee, M.D., Ph.D</last_name>
      <phone>82-32-460-3419</phone>
      <email>leekc@gilhospital.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 9, 2013</lastchanged_date>
  <firstreceived_date>August 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Medical Center</investigator_affiliation>
    <investigator_full_name>Youn Yi Jo</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
